Walgreens Boots Alliance (NASDAQ:WBA) PT Lowered to $9.00

Walgreens Boots Alliance (NASDAQ:WBA) had its price target cut by Jefferies Financial Group from $19.00 to $9.00 in a report released on Wednesday, Benzinga reports. They currently have a hold rating on the pharmacy operator’s stock.

A number of other equities analysts have also recently weighed in on the stock. TD Cowen decreased their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research report on Tuesday. Evercore ISI lifted their price objective on Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a report on Wednesday, October 16th. Bank of America reduced their target price on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research note on Wednesday, September 4th. Royal Bank of Canada cut their price target on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating on the stock in a report on Tuesday, July 2nd. Finally, Truist Financial decreased their price objective on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a report on Monday, October 7th. Four research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $12.88.

Walgreens Boots Alliance Price Performance

WBA stock opened at $9.26 on Wednesday. The firm has a market cap of $7.99 billion, a P/E ratio of -1.37, a price-to-earnings-growth ratio of 1.24 and a beta of 0.70. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. Walgreens Boots Alliance has a 1 year low of $8.22 and a 1 year high of $27.05. The stock has a 50-day simple moving average of $9.34 and a 200-day simple moving average of $12.88.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.03. The company had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The business’s quarterly revenue was up 5.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.67 earnings per share. On average, equities analysts predict that Walgreens Boots Alliance will post 1.57 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 10.80%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -14.84%.

Institutional Trading of Walgreens Boots Alliance

Hedge funds have recently made changes to their positions in the stock. Capital World Investors lifted its stake in Walgreens Boots Alliance by 57.5% in the first quarter. Capital World Investors now owns 29,061,021 shares of the pharmacy operator’s stock valued at $630,334,000 after buying an additional 10,612,373 shares during the last quarter. Thompson Siegel & Walmsley LLC lifted its position in Walgreens Boots Alliance by 98.8% in the 2nd quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock valued at $72,826,000 after purchasing an additional 2,992,648 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. boosted its stake in Walgreens Boots Alliance by 6.1% during the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 2,718,659 shares of the pharmacy operator’s stock valued at $32,882,000 after purchasing an additional 156,484 shares during the period. Newport Trust Company LLC bought a new position in Walgreens Boots Alliance in the 2nd quarter worth about $31,028,000. Finally, Ariel Investments LLC raised its holdings in shares of Walgreens Boots Alliance by 10.8% during the second quarter. Ariel Investments LLC now owns 2,038,878 shares of the pharmacy operator’s stock valued at $24,660,000 after buying an additional 198,891 shares during the last quarter. Institutional investors own 58.59% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.